Assurance de qualité pour le cancer rectal – phase 2 ...

KCE Reports 81 PROCARE – phase 2 83Quality indicator Subdiscipline(s) Source Ex/inclusion Level Final QI(s)Percentage of patients with stage II or III rectal cancer receivingchemoradiotherapyPercentage of patients receiving adjuvant radiotherapy who also receivedadjuvant chemotherapy for cancer of the sigmoid, colon or rectumRate of adjuvant radiation therapy for patients with stage II or III rectalcancerPercentage of patients with stage IV colon cancer or stage IV rectal cancerreceiving palliative chemotherapyPercentage of patients with stage IV colon or rectal cancer receivingpalliative chemotherapy, radiation therapy, or bothPercentage of patients with CRC receiving postoperative (surveillance)colonoscopyNumber of stage I to stage III CRC cases with a colonoscopy within 1 yearof surgeryPercentage of rectal cancer cases that received a post surgical endoscopicexamination within 12 months postsurgeryAdjuvant AHRQ Inclusion 2 1242Adjuvant AHRQ Inclusion 2 1242Adjuvant AHRQ Inclusion 2 1242Palliative AHRQ Inclusion 2 1251Palliative AHRQ Inclusion 2 1251Follow-up AHRQ Inclusion 2 1261Follow-up AHRQ Inclusion 2 1261Follow-up AHRQ Inclusion 2 1261Time from patient presentation with symptoms to cancer diagnosis AHRQ Exclusion 3Proportion of colonoscopies that were completed in a timely fashion AHRQ Exclusion 3Complication rate of colonoscopy AHRQ Exclusion 3Serious postendoscopic procedure complication rate AHRQ Exclusion 3Non-receipt of surgery AHRQ Exclusion 3Percentage of CRC patients who underwent cancer-directed surgery AHRQ Exclusion 3Intraprocedure colonoscopy complication rate AHRQ Exclusion 3Colonoscopy completion rate AHRQ Exclusion 3Cecal intubation rate AHRQ Exclusion 3Percentage of patients with adequate bowel preparation prior tocolonoscopyProportion of colonoscopies performed by physicians with specializedtrainingAdherence of radiotherapy management treatment guidelines for patientswith adenocarcinoma of the rectum or sigmoid colonAHRQ Exclusion 3AHRQ Exclusion 3AHRQ Exclusion 3Rate of use of modern radiation therapy techniques and adherence toAHRQ Exclusion 3recommendations of NCIsponsored randomized controlled trials in rectalcancer patientsPercentage of newly diagnosed CRC cases who were staged using theAHRQ Exclusion 3AJCC systemProportion of CRC cases in which pathologic staging preceded AHRQ Exclusion 3